国际瘤芽共识会议建议对口腔癌的影响
Katerina Kopecka1, Michal Herman1, Jaroslav Michalek2
1Department of Oral and Maxillofacial Surgery, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Oral diseases
|December 2, 2024
概括
使用2016年国际瘤芽共识会议 (ITBCC) 标准评估的瘤芽是口腔状细胞癌 (OSCC) 的一个有价值的预后指标. 高瘤芽独立预测更糟糕的生存结果.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 口腔癌研究 在口腔癌研究.
背景情况:
- 瘤芽是口腔状细胞癌 (OSCC) 的潜在预后因素.
- 在OSCC中缺乏针对瘤芽的标准化评分系统.
- 2016年国际瘤芽共识会议 (ITBCC) 提出了标准化的标准.
研究的目的:
- 用ITBCC 2016评分系统评估OSCC中的瘤芽.
- 评估OSCC中瘤芽和临床病理学参数之间的相关性.
- 确定OSCC患者瘤芽对生存的预后价值.
主要方法:
- 114个切除的OSCC病例的回顾性分析.
- 基于ITBCC标准 (低,中等,高) 的瘤芽评估.
- 统计分析包括卡普兰-梅尔生存率和考克斯回归.
主要成果:
- 瘤芽与淋巴结转移,等级,阶段,周围神经/淋巴血管入侵和局部复发有显著的相关性.
- 中级和高瘤芽独立地与较差的无病生存率有关.
- 高瘤芽率成为疾病特异性和整体生存率的独立预测因素.
结论:
- 2016年ITBCC评分系统是一种简单,可行和可重复的方法,用于评估OSCC的瘤芽.
- 根据ITBCC标准,瘤芽在切除的OSCC中显示出显著的预后价值.
- 建议将基于ITBCC的瘤芽评估纳入OSCC的组织病理学报告中.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476


